Ixico Plc (IXI) New Ord GBP0.01
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Ixico inks supply agreement with LMI
15 April 2024 09:31
(Sharecast News) - Analytics company Ixico has inked a supply agreement with Life Molecular Imaging that will see it supply that latter's Neuraceq Amyloid PET tracer for use in pharma-sponsored clinical...
-
Ixico warns on 2024 revenue amid contract delays
13 March 2024 12:25
(Sharecast News) - Medical imaging analytics company Ixico said in a trading update on Wednesday that, despite ongoing progress in expanding its opportunities pipeline, the first half of 2024 had been marked...
-
Ixico CEO to step down by end of year
12 January 2024 15:51
(Sharecast News) - Medical imaging analytics company Ixico announced on Friday that its chief executive officer Giulio Cerroni planned to retire from his position, and as a director, by the end of 2024.
-
Ixico full-year earnings could slightly exceed forecasts
29 September 2023 13:08
(Sharecast News) - Advanced medical imaging analytics specialist Ixico said in an update on Friday that its earnings for the financial year would either meet or exceed market predictions, even though it...
-
Ixico awarded new £2m, four-year contract
14 June 2023 14:17
(Sharecast News) - Medical imaging and analytics specialist Ixico has been awarded a new contract by an existing client, it announced on Wednesday, to provide imaging services for the extension study of...
-
Ixico set to report first-half loss as legacy issues unwind
10 May 2023 12:36
(Sharecast News) - Medical imaging analytics specialist Ixico reported first-half revenue of £3.2m in a trading update on Wednesday, down from £3.9m in the first six months of the 2022 financial year.
-
Ixico wins £700,000 contract with biotech company
10 March 2023 08:43
(Sharecast News) - Clinical research firm Ixico has won a contract to provide MRI imaging services for patient selection and efficacy analysis in patients with a rare form of dementia.
-
Ixico awarded two-year MRI imaging contract
9 December 2022 14:21
(Sharecast News) - Neuroscience analysis technology specialist Ixico has been selected by an unnamed, "leading" global pharmaceutical company and new client, it announced on Friday, to provide MRI...
-
Full-year revenue set to fall for Ixico
25 October 2022 14:27
(Sharecast News) - Artificial intelligence (AI) data analytics company Ixico flagged full-year revenue of £8.6m in a trading update on Tuesday, down from £9.2m year-on-year.
-
Ixico to extend work on Huntington's disease trial
14 June 2022 15:38
(Sharecast News) - Neuroimaging-focussed contract research organisation Ixico announced on Tuesday that an existing client has asked it to extend its breadth of services on their phase 1 and 2 trial into...
-
Ixico joins Huntington's disease research consortium
10 May 2022 15:16
(Sharecast News) - Neuroimaging contract research provider Ixico has entered a multi-party consortium for the early detection of Huntington's disease (HD), it announced on Tuesday.
-
Ixico confident after first-half revenues fall
25 April 2022 10:31
(Sharecast News) - Medical imaging technology company Ixico said in a trading update on Monday that it expected first-half revenues of £3.9m, down from £4.9m year-on-year.
Company announcements Announcements
-
Trading Update
13 March 2024 07:00
Ixico
-
Holding(s) in Company
29 January 2024 12:00
Ixico
-
Result of AGM
25 January 2024 16:00
Ixico
-
Directorate Change
12 January 2024 09:35
Ixico
-
Update regarding Nominated Adviser and Broker
27 December 2023 07:00
Ixico
-
Change of Auditor
15 December 2023 07:00
Ixico
-
Financial Results for year ended 30 September 2023
5 December 2023 07:00
Ixico
-
Notice of Results and Investor Presentation
27 November 2023 07:00
Ixico
-
Appointment of Independent Non-Executive Director
5 October 2023 07:00
Ixico
-
Trading Update
29 September 2023 07:00
Ixico
-
Contract Win
18 July 2023 07:00
Ixico
-
Contract Win
14 June 2023 07:00
Ixico
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.